Omicia Closes $23M Series B Financing | GenomeWeb

NEW YORK (GenomeWeb) – Omicia said today that it has completed a $23 million Series B financing round.

Several new investors participated in the round including UPMC Enterprises, Roche Venture Fund, LDV Partners, Ping An Ventures, and a large undisclosed genomics investor. Existing investors Artis Ventures, Acadia Woods Partners, and Buchanan Investments also participated in the financing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.